Importantly, the enriched signaling pathways, including PI3K-Akt, Rap-1, PPAR, and Toll-like receptor (TLR) signaling, have been closely linked to the development and pathogenesis of NAFLD/NASH and IBD43–48. The gene discussed is AKT1; the disease is metabolic dysfunction-associated steatotic liver disease.